KONDENSIERTE PYRIMIDINDERIVATE

European patent · EP3484884 · In force

Register entry

Publication number
EP3484884
Application number
EP17742678
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 11, 2017
Published
May 22, 2019
Granted
Jan 27, 2021
Protection ends at the latest
Jul 10, 2037
Next annual fee due
Jul 31, 2027
IPC classes
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 25/28 (2006.01)
Priority
EP 16179501 14.07.2016
PCT application
PCT/EP2017/067323 11.07.2017
PCT publication
WO2018/011164 18.01.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Dec 8, 2021

    Change

    Published in Swissreg on 08.12.2021

  7. Jan 27, 2021

    Granted

    Published in Swissreg on 27.01.2021

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacher Strasse 124, 4070 Basel

Inventor

JAKOB-ROETNE, Roland

4070 Basel

BARTELS, Bjoern

4070 Basel

REUTLINGER, Michael

4070 Basel

RATNI, Hasane

4070 Basel

LIMBERG, Anja

4070 Basel

STEINER, Sandra

4070 Basel

NEIDHART, Werner

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.